Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

In the spirit of reconciliation, Australian Associated Press acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our ...

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

Universities and medical centres have already had to cut costs as the US government slashed spending on a range of programmes ...

Dr. David Kessler, former FDA commissioner, talks with Rachel Maddow about how Donald Trump's medical evaluation forms show ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Researchers examine how cinnamon interacts with prescription medications. Cinnamon is one of the oldest and most widely used ...

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative ...